Please use this identifier to cite or link to this item:
http://repo.knmu.edu.ua/handle/123456789/31336
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Караченцев, Юрій Іванович | - |
dc.contributor.author | Кравчун, Нонна Олександрівна | - |
dc.contributor.author | Karachentsev, Yurii Ivanovych | - |
dc.contributor.author | Kravchun, Nonna Oleksandrivna | - |
dc.contributor.author | Tyzhnenko, T. | - |
dc.contributor.author | Misyura, K. | - |
dc.contributor.author | Gorshunska, M. | - |
dc.contributor.author | Pochernyaev, A. | - |
dc.contributor.author | Krasova, N. | - |
dc.contributor.author | Gladkih, A. | - |
dc.contributor.author | Leshchenko, Z. | - |
dc.contributor.author | Fedorova, G. | - |
dc.contributor.author | Plohotnichenko, O. | - |
dc.contributor.author | Hromakovska, O. | - |
dc.contributor.author | Kolesnikova, A. | - |
dc.contributor.author | Jаnsen, E. | - |
dc.contributor.author | Роltorak, V. | - |
dc.date.accessioned | 2022-12-07T08:07:26Z | - |
dc.date.available | 2022-12-07T08:07:26Z | - |
dc.date.issued | 2022-08-01 | - |
dc.identifier.citation | IInvestigation of 2548G>A leptine gene polymorphic variant impact on risk of non-alcoholic fatty liver disease in patients with type 2 diabetes mellitus / T. V. Tyzhnenko, K. V. Misyura, N. O. Kravchun, M. Yu. Gorshunska, A. K. Pochernyaev, N. S. Krasova, A. I. Gladkih, Z. A. Leshchenko, G. V. Fedorova, O. O. Plohotnichenko, O. B. Hromakovska, A. O. Kolesnikova, E. Jаnsen, Yu. I. Karachentsev, V. V. Роltorak // Проблеми ендокринної патології. – 2022. – № 3. – С. 42–52. – DOI: https://doi.org/10.21856/j-PEP.2022.3.06. | en_US |
dc.identifier.uri | http://repo.knmu.edu.ua/handle/123456789/31336 | - |
dc.description.abstract | Background. It is known that single nucleotide polymorphisms (SNPs) in adipokine genes can influence the development of pathological conditions associated with obesity, type 2 diabetes mellitus (T2D), non-alcoholic fatty liver disease (NAFLD) and their complications. In this study, we aimed to investigate the link between common -2548G > A (rs7799039) promoter variant of the human leptin gene (LEP) with leptin levels in type 2 diabetes patients with non-alcoholic fatty liver diseasese. Materials and methods. 61 patients with T2D aged from 28 to 80 years old (34 men / 27 women, age 56.40 ± 0.62 yrs, diabetes duration 7.72 ± 0.45 yrs, BMI 32.20 ± 0.43 kg/m2, WHR 1,00 ± 0,01, HbA1c 7.80 ± 0.19 %) with varying degrees of glycemic control and overweight, without renal insufficiency and 51 sex and age-match control subjects were examined. Genotyping according to SNP LEP 2548G > A was performed using the polymerase chain reaction method with appropriate primers and HhaI endonuclease. Results. In our study of T2DM patients with NAFLD compared to T2D patients without NAFLD features of dyslipidemia i.e. significant increase in triglycerides (p < 0,001), LDL cholesterol (p < 0,1), lower HDL cholesterol (p < 0.001) were found. Stratification of the diabetic patients in the presence and absence of NAFLD showed more pronounced increase in circulating leptin levels in the presence of NAFLD (84.73 ± 13.80 vs. 52.57 ± 6.86 μg/L, respectively), (p < 0.01), which justifies the feasibility of using this indicator for further needs as a diagnostic parameter of the above complication. In our study in GG carriers genotype of the G2548A LEP gene polymorphic locus type 2 diabetes patients with NAFLD the highest level of leptin was observed (159.15 μg/L), compared to other genotypes. Thus, it can be assumed that the G allele is associated with increased leptin levels in the blood of patients with NAFLD. This study showed that women with type 2 diabetes mellitus carrying the GG genotype with the G-2458A polymorphic variant of the LEP gene have 3.4 times higher leptin levels than men carrying the same genotype (p < 0.03). Conclusions. The data obtained regarding the 2548G > A polymorphic variant of the LEP gene can be used as a basis for personalized prevention and the formation of risk groups for the development of NAFLD | en_US |
dc.description.sponsorship | The institution that finances the study is the National Academy of Medical Sciences of Ukraine. The authors assume responsibility for the published work. The authors guarantee absence of competing interests and their own financial interest when carrying out the research and writing the article | en_US |
dc.language.iso | en | en_US |
dc.subject | type 2 diabetes mellitus | en_US |
dc.subject | single nucleotide polymorphisms | en_US |
dc.subject | non-alcoholic fatty liver disease | en_US |
dc.subject | leptin | en_US |
dc.title | Investigation of 2548G˃A leptine gene polymorphic variant impact on risk of non-alcoholic fatty liver disease in patients with type 2 diabettes mellitus | en_US |
dc.title.alternative | Дослідження впливу поліморфного варіанту 2548G >A гена лептину на ризик розвитку неалкогольної жирової хвороби печінки у хворих на цукровий діабет 2 типу | en_US |
dc.type | Article | en_US |
Appears in Collections: | Наукові праці. Кафедра ендокринології та дитячої ендокринології |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
Караченцев_Кравчун_3_1025-Article Text-2264-1-10-20220915.pdf | 342,53 kB | Adobe PDF | View/Open |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.